DSM-FIRMENICH AG DSM-Firmenich AG Share Price Börse Stuttgart
Equities
ZX61
US23346J1034
Consumer Goods Conglomerates
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.2 EUR | -1.92% |
|
+0.99% | 0.00% |
| 06-26 | DSM-Firmenich Unit Issues EUR800 Million Bond | MT |
| 06-26 | DSM-Firmenich Issues ?800 Million Long-Term Bond | CI |
| Sales 2024 * | 12.6B 13.5B 1,068B | Sales 2025 * | 13.27B 14.22B 1,125B | Capitalization | 28.01B 30.01B 2,375B |
|---|---|---|---|---|---|
| Net income 2024 * | 459M 492M 38.91B | Net income 2025 * | 795M 852M 67.4B | EV / Sales 2024 * | 2.45 x |
| Net Debt 2024 * | 2.84B 3.04B 240B | Net Debt 2025 * | 2.57B 2.75B 218B | EV / Sales 2025 * | 2.3 x |
| P/E ratio 2024 * |
61
x | P/E ratio 2025 * |
35.2
x | Employees | - |
| Yield 2024 * |
2.38% | Yield 2025 * |
2.34% | Free-Float | 25.03% |
More Fundamentals
* Assessed data
More news
Latest transcript on DSM-Firmenich AG
More press releases
| 1 week | +0.99% | ||
| Current month | -0.97% | ||
| 1 month | -1.92% |
1 week
9.85
10.50
1 month
9.2010.50
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 31/12/89 | |
Ralf Schmeitz
DFI | Director of Finance/CFO | - | 31/08/23 |
Sarah Reisinger
CTO | Chief Tech/Sci/R&D Officer | 45 | 31/12/22 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 31/01/23 | |
Thomas Leysen
CHM | Chairman | 63 | 31/01/23 |
| Director/Board Member | 62 | 31/01/23 |
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 10.2 | -1.92% |
| 27/06/24 | 10.4 | +0.97% |
| 26/06/24 | 10.3 | +0.98% |
| 25/06/24 | 10.2 | 0.00% |
| 24/06/24 | 10.2 | +0.99% |
Delayed Quote Börse Stuttgart, June 28, 2024 at 02:28 pm
More quotes
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
Sector
Consumer Goods Conglomerates
Calendar
30/07/2024
- Q2 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
105.6
EUR
Average target price
122.9
EUR
Spread / Average Target
+16.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +12.83% | 878B | |
| +24.56% | 174B | |
| +1.83% | 139B | |
| +77.04% | 104B | |
| -9.54% | 70.71B | |
| -6.52% | 56.55B | |
| +109.08% | 35.99B | |
| +28.44% | 33.33B | |
| -37.23% | 32.12B |
- Stock Market
- Equities
- DSFIR Stock
- ZX61 Stock
